Download Products - Hampshire LPC website

Products Miscellany and Supply Problems June 2014
Products
Product Information
Products with a Supply Problem or Discontinued
LoFric Product codes
A range of LoFric product codes have
(Wellness Direct)
been discontinued and have been
replaced by alternative codes.
See:
Comments
The “previous codes” are still displayed on GP
systems, with advice that the products have been
discontinued.
Pharmacy_Flyer_v4_
with_2022.pdf
Supply Now Available
Biotin
A licensed Biotin supplement has been
launched by GlucoRx called OroB7
5mg tablet, pack of 30 costs £33.99.
OroB7 is available via local wholesalers
and is prescribable on GP systems.
Please note that Biotin is non-formulary
locally.
Metoject® (50mg/1ml
methotrexate) pre-filled pens
The switch from syringes to pens will
take effect from the 1st July 2014; from
this date hospitals will no longer be able
to order the syringes, there may be
some stock available in community for a
short period. GP systems will be
updated on the 1st July to reflect the
change.




Same price
Same route of distribution
Same 10 dose range
Same colour coding
Biotin also known as vitamin H or coenzyme R, is a
water-soluble B-vitamin (vitamin B7). Biotin is
necessary for cell growth, the production of fatty
acids, and the metabolism of fats and amino acids.
There is a professional requirement that where a
product is ordered on a prescription, a pharmacist
must supply a product with a marketing
authorization, where such a product exists and is
available, in preference to an unlicensed medicine.
Metoject Pen® presents in the following strength
single pens:
7.5mg/0.15ml
10mg/0.2ml
12.5mg/0.25ml
15mg/0.3ml
17.5mg/0.35ml
20mg/0.40ml
22.5mg/0.45ml
25mg/0.50ml
27.5mg/0.55ml
30mg/0.60ml
The change in device requires a
different technique for the patients to
self administer and as such there is
some patient education material to
reflect this, please visit
:www.metoject.co.uk
Viteyes® products
Viteyes® products are changing:
Vitamins in Age Related Macular Degeneration:
Older Viteyes® products are being
discontinued over the coming months
and these products need to be switched
to the newer formulations:
Local guidance was to reflect recent trial evidence it was agreed that these may be prescribed locally
(although unlicensed) for a very specific group of
patients in whom there is some evidence of benefit.
Specifically, patients with ‘category 4’ disease who
have advanced disease in one eye only (advanced
lesions or visual acuity <20/32).
Viteyes Original® switch to Viteyes 2®
Viteyes Original Plus Lutein® switch to
Viteyes 2®
Viteyes plus Lutein BC free® switch to
Viteyes 2®
Information for Community Pharmacists
Revised SPC: Univer®
The SPC has been updated with a
(verapamil) 120/180/240mg
warning that verapamil can cause
Prolonged Release
uterine muscle relaxation and this
Capsules
possibility should be considered in
pregnancy at term.
Tin Orchel Medicines Management Team Southampton City CCG
‘Viteyes 2 formula’ is the preferred product as it is
least expensive and contains the correct
combination of vitamins and zinc. Prescribing in
‘category 4’ patients normally initiated on
secondary care advice, but patients may opt to
purchase these OTC.
Verapamil tablets are currently AMBER in the local
formulary.
E-mail [email protected]
Products Miscellany and Supply Problems June 2014
Revised SPC: Decapeptyl®
(triptorelin) SR
3mg/11.25mg/22.5mg
Revised SPCs: Depixol®
(flupentixol) injections and
tablets
General Information
St John’s Wort
Legislative changes will
come into force on Tuesday
10 June 2014
Section 4.2 now states that in patients
treated with GnRH analogues for
metastatic prostate cancer, treatment is
usually continued upon development of
castrate-resistant prostate cancer.
Reference should be made to relevant
guidelines.
Information on leukopenia, neutropenia
and agranulocytosis has been added to
section 4.4 (warnings and precautions);
information on adverse events that may
have a negative impact on female
and/or male sexual function and fertility
has been added to section 4.6 (fertility).
Triptorelin injections are currently AMBER in the
local formulary.
MHRA Drug Safety Update warns that
St John’s Wort impairs the effectiveness
of hormonal contraceptives. The risk
affects all hormonal contraceptives
including long-acting reversible
implants-but there is no evidence on
whether it affects intrauterine devices.
Tramadol will become a Schedule 3
controlled drug (CD No Register POM),
but will be exempt from safe custody
regulations.
Zopiclone and Zaleplon will become
Schedule 4 Part 1 controlled drugs (CD
Benz POM).
For more information see MHRA Safety Update
(2014; Issue 8).
Flupentixol injections and tablets are currently
GREEN in the local formulary.
Changes of note are :
A prescription for a controlled drug in schedules 2,
3, or 4 is valid for 28 days from the date stated on
the prescription.
The quantities prescribed for schedule 2, 3, 4
should not exceed 30 days’ supply.
Tramadol cannot be prescribed in the repeat
dispensing system or sent via EPS.
Specials information
Rosemont App.
There is now a free Rosemont
Specials/Licensed liquid medicines App
for Android and IPhones:
Go to www.rosemontpharma.com
to download or visit your App store.
Tin Orchel Medicines Management Team Southampton City CCG
E-mail [email protected]